EcoR1 Capital LLC 13D and 13G filings for SpringWorks Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 6:41 pm Sale |
2023-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX |
EcoR1 Capital LLC | 0 0.000% |
-3,460,208 (Position Closed) |
Filing |
| 2022-09-19 08:27 am Purchase |
2022-09-07 | 13G | SpringWorks Therapeutics, Inc. SWTX |
EcoR1 Capital LLC | 3,460,208 5.500% |
3,460,208 (New Position) |
Filing |